Cargando…
Correction: Reversion of resistance to oxaliplatin by inhibition of p38 MAPK in colorectal cancer cell lines: involvement of the calpain / Nox1 pathway
Autores principales: | Chocry, Mathieu, Leloup, Ludovic, Kovacic, Hervé |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6003572/ https://www.ncbi.nlm.nih.gov/pubmed/29928496 http://dx.doi.org/10.18632/oncotarget.25605 |
Ejemplares similares
-
Reversion of resistance to oxaliplatin by inhibition of p38 MAPK in colorectal cancer cell lines: involvement of the calpain / Nox1 pathway
por: Chocry, Mathieu, et al.
Publicado: (2017) -
Gemcitabine: An Alternative Treatment for Oxaliplatin-Resistant Colorectal Cancer
por: Chocry, Mathieu, et al.
Publicado: (2022) -
Correction: Inhibition of p38 MAPK Signaling Augments Skin Tumorigenesis via NOX2 Driven ROS Generation
por: Liu, Liang, et al.
Publicado: (2017) -
Antioxidant, Antimutagenic, Tanning and Calpain Induction Activities of Methanolic Extract of Tunisian Plant (Moricandia Arvensis)
por: Skandrani, Ines, et al.
Publicado: (2017) -
Correction for: microRNA-363-3p reduces endothelial cell inflammatory responses in coronary heart disease via inactivation of the NOX4-dependent p38 MAPK axis
por: Zhou, Tao, et al.
Publicado: (2022)